It was an amazing experience for us to be a part of the 48th Annual Conference of ACBICON 2022. We would like to thank all the delegates and doctors who visited our stall and interacted with us. The event was indeed a success with your presence.
Navi Mumbai, 2nd February, 2022 – DiaSys Diagnostics India Private Limited has been Great Place to Work®-Certified in India (from February, 2022 to February, 2023). DiaSys India believes that the core values and culture of the organization is instrumental in getting this achievement. Our teams are our biggest strength and the passion, dedication and attributes they bring, owes this achievement.
On this joyous occasion of the festival of lights, DiaSys India wishes you and your family health, wealth and prosperity! A very Happy Diwali from our family to yours...!
DiaSys wishes to announce that we have achieved another milestone in the Indian IVD Industry. On the completion of 7 successful years, we would like to take this occasion to embrace each one of you for being an earnest part of DiaSys Diagnostics India Private Limited.
On 13th August 2021, we inaugurated our new Regional Office. We started the day with a Ganapathi Pooja at our office, to offer our prayers to the almighty and seek the blessings.
The celebration of the 75th Independence Day, was done in a very unique style at DiaSys India.
The new DiaSys reagent Procalcitonin FS is a fluid-stable, particle enhanced immunoturbidimetry assay, providing a convenient workflow on clinical chemistry analysers.
Measuring range from 0.2 ng/mL to 50 ng/mL.
QDx UriLyzer100 Pro - A semi-automated, rapid, reliable, robust solution for routine urine analysis.
QDx UriLyzer100 Pro is a trusted system for laboratories, hospitals and doctor’s clinic.
The analyzer in combination with urine test strips QDx Urine10 Pro provides pertinacious, efficient and high quality test results.
DiaSys India successfully commences pre-marketing activities of the most awaited product in DiaSys portfolio. We are in the process to launch “World’s First Truly Modular Electrolyte Analyzer” in a couple of weeks.
The evaluation of the product was successfully conducted at 4 different locations, namely Clinitech Computerized Laboratory, UDC Laboratory in the Mumbai region, Palliwal Diagnostics, Kanpur & Charak Diagnostics, and Lucknow. We received an overwhelming response from all four centers.
QDx Instalyte is a patented* product which is conceptualized, designed, developed and manufactured by R&D team at DiaSys India.
Its features are as follows:
• All in One Universal Cartridge*
• Zero Maintenance
• ISE Technology
*patent no. 33904
DiaSys India has been awarded the certificate of ICMED 13485; Certificate Registration Number 9940000025, on 8th April 2020, for its Mahape, Navi Mumbai facility.
The audit was carried out by TUV SUD South Asia- the first certification body in India to be accredited by NABCB for certifying Medical Devices Organization under ISO 13485 and ICMED Scheme.
TUV SUD South Asia awarded this certificate to DiaSys India under the scope of “Manufacturing & Distribution of In-Vitro Diagnostic Products (Biochemistry & Hematology Reagents, Rapid Test Strips and Analyzers).
DiaSys India is one among the only five IVD companies in India today to be certified for the ICMED 13485.